| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |